Nick Goulden is one of the UK’s leading experts in childhood leukaemia.
He was instrumental in incorporating the detection of minimal residual disease (MRD)
into treatment stratification for childhood acute lymphoblastic leukaemia (ALL) and through his involvement in the last two national clinical trials for ALL, he has helped deliver amongst the best outcomes achieved internationally for this disease.
Nick is a member of the Children’s Cancer and Leukaemia Group (CCLG)
leukaemia task force and the European Study Group on minimal residual disease.
He is also a peer reviewer for prestigious international journals such as The Lancet, the British Journal of Haematology, and Leukaemia. Professor Silvia Marino MD, FMH-Path Professor of Neuropathology and Honorary Consultant Neuropathologist, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London
Silvia Marino studied medicine at the University of Turin in Italy before training in neuropathology and histopathology in Zurich and molecular genetics in Amsterdam. She has led her own research group at the Blizard Institute in London since 2006.
Silvia brings great expertise in the biology of brain tumours. The aim of her group is to understand how biological properties of stem cells, such as self-renewal and differentiation, are controlled and how this knowledge can be applied to understand the molecular basis of diseases including brain cancer. She has published widely on medulloblastoma.
Silvia is a member of the Council of the British Neuro-oncology Society and is on the organising committee of the Glioma Club. Professor Geoffrey Pilkington BSc PhD CBiol FSB FRCPathProfessor of Cellular and Molecular Neuro-oncology, University of Portsmouth
Geoff has more than 40 years’ experience in brain tumour research. He has published a wealth of scientific papers, sits on multiple scientific advisory and editorial boards and has lectured on brain tumours throughout the world.
Geoff’s laboratories at the University of Portsmouth represent the Brain Tumour Research
flagship centre for dedicated brain tumour research, boasting state-of-the-art neuro-oncology research facilities including a microscope imaging suite and a brand new molecular laboratory.
Geoff established the South of England Brain Tumour Alliance (SEBTA
) to facilitate the sharing of expertise, information and resources between seven regional bases with a strong interest and involvement in diagnosis, treatment and research in neuro-oncology.
He is past President of the British Neuro-oncology Society (BNOS) and an Executive Board Member of the European Association for Neuro-oncology.